Top

Global Acute Lymphocytic/Lymphoblastic leukemia Market 2015-2019

Category : Healthcare  | Published Date : Nov-2015 | Pages : 65
enquire GET DISCOUNT
Global Acute Lymphocytic Leukemia Market 2015-2019
Covering: An in-depth study of the acute lymphocytic leukemia market and segmentation by route of administration (oral and parenteral), by type of molecules (biologics and small molecules), and by geography (the Americas, EMEA, and APAC). The report also presents a detailed analysis of the top companies operating in the market, including Amgen, Bristol-Myers Squibb, and Novartis.

Market landscape of acute lymphocytic leukemia
Acute lymphocytic leukemia or acute lymphoblastic leukemia, is a malignancy of the blood cells that affects the lymphoblasts or leukemic blasts, which witnesses an uncontrolled cell division. The main symptoms a patient exhibits are weakness, tiredness, dizziness, fever, shortness of breath, frequent infections, bruising, and bleeding. 

Currently, the disease cannot be cured completely but the risk can be reduced by administering medication.

Technavio’s market research analysts expect the global acute lymphocytic leukemia market to grow at a steady rate and post a CAGR of over 4% during the forecast period. One of the major factors contributing to the growth of the market is the provision for orphan drugs. For instance, in the US, orphan designation for a drug means incentives like tax credits for qualified clinical testing, exemption from prescription drug user fees unless indicated for additional non-orphan indications, and market exclusivity for seven years.

Segmentation of the acute lymphocytic leukemia market by route of administration
• Oral
• Parenteral

Many medications are administered through the oral route to guarantee a systemic effect. The oral route is a sub-division of enteral administration and is considered to be one of the safest and most preferred routes of drug administration.

Geographical segmentation of the acute lymphocytic leukemia market
• Americas
• APAC
• EMEA

With a share of over 49%, the Americas dominated the acute lymphocytic leukemia market, with the US being the major revenue contributor. The Americas is closely followed by the EMEA and the APAC region and the market is expected to follow a similar trend during the forecast period.

Competitive landscape and key vendors
The acute lymphocytic leukemia market is marked by the presence of both global and local drug manufacturers with varied product portfolios containing generic and off- label drugs as well as branded therapies. Besides, the high level of unmet medical need is expected to give a platform to the vendors to develop products to cater to relevant areas and enhance their market shares.

Primary vendors in this market are - 
• Amgen
• Bristol-Myers Squibb
• Novartis

Other prominent vendors included in this report are Ariad, Arno Therapeutics, Baxter, Boehringer Ingelheim, ERYTECH Pharma, Fate Therapeutics, Jazz Pharmaceuticals, Orphan Europe, Otsuka, Ono Pharmaceuticals, Onconova Therapeutics, Pfizer, Regeneron Pharmaceuticals, Sanofi, and Sigma-Tau Pharmaceuticals.

Key questions answered in the report include
• What will the market size and the growth rate be in 2019?
• What are the key factors driving the global acute lymphocytic leukemia market? 
• What are the key market trends impacting the growth of the global acute lymphocytic leukemia market? 
• What are the challenges to market growth?
• Who are the key vendors in the global acute lymphocytic leukemia market?
• What are the market opportunities and threats faced by the vendors in the global acute lymphocytic leukemia market?
• What are the trending factors influencing the market shares of the Americas, EMEA, and APAC?
• What are the key outcomes of the five forces analysis of the global acute lymphocytic leukemia market? 

Technavio also offers customization on reports based on specific client requirement.

Related reports
• Global Chronic Lymphocytic Leukemia Therapeutics Market 2015-2019
• Global Acute Myeloid Leukemia Therapeutics Market 2015-2019
• Global Acute Coronary Syndrome (ACS) Market 2015-2019
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Product profiles
PART 04: Market research methodology
Research methodology
Economic indicators
PART 05: Introduction
Key market highlights
PART 06: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 07: Disease overview
Etiology and risk factors
Pathophysiology
Symptoms
Epidemiology
Classification
Diagnosis
Treatment and management
PART 08: Market segmentation by route of administration
Oral
Parenteral
PART 09: Market segmentation by type of molecules
Biologics
Small molecules
PART 10: Geographical segmentation
Global acute lymphocytic leukemia therapeutics market by geography 2014
Acute lymphocytic leukemia market in Americas
Acute lymphocytic leukemia market in EMEA
Acute lymphocytic leukemia market in APAC
PART 11: Market drivers
PART 12: Impact of drivers
PART 13: Market challenges
PART 14: Impact of drivers and challenges
PART 15: Market trends
PART 16: Vendor landscape
Competitive scenario
Market share analysis
Other prominent vendors
PART 17: Key vendor analysis
Amgen
Bristol-Myers Squibb
Novartis
PART 18: Appendix
List of abbreviation
PART 19: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Global acute lymphocytic leukemia therapeutics market 2014-2019 ($ millions)
Exhibit 03: Five forces analysis
Exhibit 04: Global acute lymphocytic leukemia therapeutics market by geography 2014
Exhibit 05: Global acute lymphocytic leukemia therapeutics market revenue by geography 2014-2019 ($ millions)
Exhibit 06: Global acute lymphocytic leukemia therapeutics market revenue by geography (percentage)
Exhibit 07: Acute lymphocytic leukemia market in Americas 2014-2019 ($ millions)
Exhibit 08: Acute lymphocytic leukemia market in EMEA 2014-2019 ($ millions)
Exhibit 09: Acute lymphocytic leukemia market in APAC 2014-2019 ($ millions)
Exhibit 10: Impact of drivers
Exhibit 11: Impact of drivers and challenges
Exhibit 12: Key takeaways: Amgen
Exhibit 13: Global sales of Sprycel 2012-2014 ($ millions)
Exhibit 14: Key takeaways: Bristol-Myers Squibb
Exhibit 15: Global sales of Gleevec/Glivec 2012-2014 ($ millions)
Exhibit 16: Key takeaways: Novartis
Exhibit 17: Amgen: Business segmentation by revenue 2014
Exhibit 18: Amgen: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 19: Amgen: Geographical segmentation by revenue 2014
Exhibit 20: Business segmentation by revenue 2013 and 2014 ($ billions)
...
Publisher Name : Technavio

SIMILAR MARKET STUDIES

Please Select Format
Single User: US $ 2500
Five User: US $ 3000
Site User: US $ 4000
Global User: US $ 10000

NEED MORE INFORMATION
Contact us
Call us +1-971-202-1575
--- or ---
help@bigmarketresearch.com
WHY BIG MARKET RESEARCH
With high quality and penned to perfection, Big Market Research is an exclusive online market to get best market research reports for your business needs and strategies. We recommend you to stop browsing as soon as you discover our website. This is because we firmly believe that once you reach here; all your business concerns will be addressed.

We have a huge collection of market research report from numerous filed which will provide you with all the necessary solution. We make sure that reports that we sell are true in context, have a quality that is unrivaled, fully integrated with equal spread of opinion. They will give you proper insights into different opportunities one may locate for their start-up pr expansion.

Let your qualms and concern be sidelined through our high end syndicated as well as customized reports.
Top